VirtuS-Investment-Advisers

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
473
Total Value
367795360
Accession Number
0000019481-25-000015
Form Type
13F-HR
Manager Name
VirtuS-Investment-Advisers
Data Enrichment
95% identified
447 identified26 unidentified

Holdings

473 positions • $367.8M total value
Manager:
Search and click to pin securities to the top
Page 20 of 24
Berry Corp (bry)
Shares:39.6K
Value:$127.0K
% of Portfolio:0.0% ($127.0K/$367.8M)
Disc Medicine, Inc.
Shares:2.6K
Value:$126.9K
% of Portfolio:0.0% ($126.9K/$367.8M)
Dianthus Therapeutics, Inc. /DE/
Shares:7.0K
Value:$126.7K
% of Portfolio:0.0% ($126.7K/$367.8M)
Scholar Rock Holding Corp
Shares:3.9K
Value:$126.6K
% of Portfolio:0.0% ($126.6K/$367.8M)
SITE Centers Corp.
Shares:9.7K
Value:$124.5K
% of Portfolio:0.0% ($124.5K/$367.8M)
RECURSION PHARMACEUTICALS, INC.
Shares:23.5K
Value:$124.4K
% of Portfolio:0.0% ($124.4K/$367.8M)
AbCellera Biologics Inc.
Shares:55.6K
Value:$124.1K
% of Portfolio:0.0% ($124.1K/$367.8M)
Apple Hospitality REIT, Inc.
Shares:9.6K
Value:$124.0K
% of Portfolio:0.0% ($124.0K/$367.8M)
iTeos Therapeutics, Inc.
Shares:20.7K
Value:$123.4K
% of Portfolio:0.0% ($123.4K/$367.8M)
Viridian Therapeutics, Inc.\DE
Shares:9.1K
Value:$123.1K
% of Portfolio:0.0% ($123.1K/$367.8M)
CIVITAS RESOURCES, INC.
Shares:3.5K
Value:$122.1K
% of Portfolio:0.0% ($122.1K/$367.8M)
Verve Therapeutics, Inc.
Shares:26.3K
Value:$120.4K
% of Portfolio:0.0% ($120.4K/$367.8M)
MoonLake Immunotherapeutics
Shares:3.0K
Value:$119.2K
% of Portfolio:0.0% ($119.2K/$367.8M)
Allogene Therapeutics, Inc.
Shares:81.3K
Value:$118.7K
% of Portfolio:0.0% ($118.7K/$367.8M)
Bicara Therapeutics Inc.
Shares:9.1K
Value:$118.5K
% of Portfolio:0.0% ($118.5K/$367.8M)
Cogent Biosciences, Inc.
Shares:19.7K
Value:$117.9K
% of Portfolio:0.0% ($117.9K/$367.8M)
ArriVent BioPharma, Inc.
Shares:6.3K
Value:$117.4K
% of Portfolio:0.0% ($117.4K/$367.8M)
American Assets Trust, Inc.
Shares:5.8K
Value:$116.1K
% of Portfolio:0.0% ($116.1K/$367.8M)
uniQure N.V.
Shares:10.9K
Value:$115.6K
% of Portfolio:0.0% ($115.6K/$367.8M)
ACELYRIN, Inc.
Shares:46.4K
Value:$114.5K
% of Portfolio:0.0% ($114.5K/$367.8M)